Sunday, August 14, 2011

New Gun Law Restricts Health Care Providers

Florida recently passed a law making it illegal for doctors to ask patients whether there is a gun in their house during a routine health care visit. The law, CS/CS/ HB155, which became effective in early June, makes some exceptions for EMTs and paramedics, who frequently treat people injured by gun violence.

But the law's wording makes it clear that Florida firearm owners are primarily concerned about their own privacy. The law prohibits recording firearm ownership in a patient's medical record, prohibits "harassment of patient regarding firearm ownership during examination," and prohibits "discrimination by insurance companies" against firearm owners.

Asking about, or counseling against, gun ownership is not an idle issue. As physician Erin N. Marcus points out in a New York Times essay on this topic:
As a general internist in South Florida, I often see the effects of gun violence. Many of my patients have been injured or disabled by a gunshot, or had a family member shot and killed. Shortly after the new law went into effect, local television stations broadcast a story about a 4-year-old in Miami who was accidentally shot by his 17-year-old half brother, who was playing with a .22-caliber rifle.

Asking patients questions about their sexual habits, alcohol consumption, gun ownership, and other "off-limit" topics is part of a doctor's job in providing good health care to a patient. This information is used privately by the doctor to ensure better care, not reported to local authorities. Questions from health care providers about illegal activities, such as illegal drug use or texting while driving (illegal in some states) don't provoke public outrage. Questions about legal gun possession do.

Sunday, August 7, 2011

Recruiting Providers Who Trained Abroad

With a shortage of health care providers looming, the U.S. is trying to tap foreign-trained professionals to fill the gap. There are two tactics to achieve this, as several recent articles in Fierce Healthcare point out: giving temporary visas to nurses currently living and working abroad, and creating on-ramps for foreign-trained health care professionals living in the U.S. to practice medicine again.

As Fierce Healthcare points out, these policies would not just increase the number of people practicing medicine in the U.S., they would also add more diversity and language/cultural competency skills to the current health care workforce.

A bill approved by the House of Representatives, H.R. 1933, would double the length of time that foreign-trained nurses could work in U.S. hospitals from three years to six years, although the bill allows fewer of these visas than were granted in the past. These nurses would work in areas with nursing shortages that also serve Medicare and Medicaid patients, the Fierce Healthcare article explains.

Fierce Healthcare points out that, despite a crushing shortage of tens of thousands of health care professionals nationwide, this bill only grants 300 visas and serves about a dozen hospitals. Many of these hospitals are located in the bill sponsor's home state of Texas.

Meanwhile, the Welcome Back Initiative seeks to recruit underemployed foreign-trained U.S. residents back into medicine. The initiative funds free resource centers that provide information on getting appropriate credentials to practice in the U.S., educational programs, and job opportunities. The initiative currently serves only nine areas of the country, however, virtually ignoring the Midwest and the South.

These recruitment tools, if limited (and, I suspect, politically fraught), are at least a step in the right direction toward solving a serious provider shortage in health care.

Saturday, July 30, 2011

Can Stem Cells Stop MS?

Later this year, a small clinical trial will begin in Europe to test the use of stem cells to manage or possibly reverse the progress of multiple sclerosis, a disease in which a patient's immune system attacks the myelin sheath that protects nerve cells from damage. The disease tends to first strike when a patient is in their 20s and 30s, and it causes a range of symptoms (which vary widely by patient) such as fatigue, numbness, and balance problems.

For the trial, stem cells will be taken from patients' bone marrow and then injected into their blood, Pallab Ghosh reported for BBC News Health ("Doctors begin major stem cell trial for MS patients"). Promising earlier studies have used these stem cells to "retrain" the patient's immune system not to attack the myelin sheath.

Multiple sclerosis is more common in areas farther from the equator, such as the UK and the northern United States, as this fascinating geographic map of cases illustrates. The incidence of MS appears to be increasing, particularly among women, with some blaming the Western diet and vitamin D deficiency.

Ghosh points out that this trial also aims to address the problem of medical tourism among MS patients, who sometimes seek expensive and unproven stem cell treatments outside the UK. The trial will provide scientific evidence of the efficacy of stem cell treatment.

The phase II trial begins at the end of the year, investigating whether stem cell treatment is effective in human subjects and what side effects it might cause. The trial includes 150 patients and is predicted to take five years, with a possible phase III trial (comparing stem cell treatment to standard MS treatments) to follow before any new treatment can be brought to market.

Sunday, July 24, 2011

The Business of Health Care Can Make You Sick

The business of health care is not always good for your health, at least if you look at the ongoing problems at Johnson & Johnson (J&J). I've written before about problems with the company's McNeil division, which manufactures many household medicines such as children's Tylenol. Over the past two years, some products manufactured at McNeil have been recalled due to musty odors, inadequate active and inactive ingredients, or metal particles found in some of the bottles.

Ultimately, J&J shareholders sued the company. In response, board members recently filed a 122-page report in federal court that examined what they believe went wrong at the company.

In an article about the report earlier this week, Businessweek's Alex Nussbaum and David Voreacos explained that the trouble seemed to begin when J&J acquired Pfizer's consumer health-care unit in 2006, which added many products to the company and strained manufacturing facilities. Management turnover, staffing cuts, and squabbles between different groups of staff contributed to quality control issues as well, Businessweek reported ("J&J Blames Staff Cuts, Pfizer Deal for Tylenol Recall Flood").

Businessweek pointed out that Johnson & Johnson has recalled a range of products over the past year, including "contact lenses, artificial hips, insulin cartridges and prescription drugs across J&J's 250 subsidiaries." Because so many people use their products, the problems at Johnson & Johnson are everyone's problems. What exactly is in that bottle of Tylenol in your medicine cabinet? That depends on how J&J makes and implements its business decisions.

Wednesday, July 13, 2011

The Fi ve Percent

A recent study found that about half of U.S. health care expenses are incurred by just five percent of U.S. patients. These 2009 figures were just released in a data brief by the nonprofit National Institute for Health Care Management Research Foundation. The data brief found that the U.S. spent an average of $8,086 per person on health care in 2009, almost twice the $4,166 per-capita cost in 1997. Ranked by expense, the top 5% of patients (civilian and non-institutionalized) cost a mean of $35,820 per year, and the top 1% of patients cost $76,476 per year in 2009, according to the brief.

Who are these high-cost patients, the five percent? The brief stated that they tend to be 55 or older and have at least one chronic condition. (I've read elsewhere that  patients with chronic conditions consume 75% of the health care budget.). Many of them have hypertension, high cholesterol, or diabetes. Increasing obesity rates are driving the increase in many costly chronic conditions.

Other factors are also driving up health care costs. These factors include costly new medical technologies, the increased use of defensive medicine to avoid malpractice suits, and economic incentives such as fee-for-service payments that discourage adequate management of chronic conditions, according to the brief.

The brief did not have any suggestions about how to curb health care expenses. Clearly, the rate of chronic conditions in the U.S. is one of the roots of the problem (although other reforms are also needed in the health care system). But the time and energy it takes for an individual to prevent or adequately manage a chronic condition are at odds with our culture, which rewards unhealthy workaholism and weakens the community ties that can foster healthy choices.

Tuesday, June 28, 2011

"Mommy, why is my hot dog bun blue?"

I'm a bit of a food safety zealot, poking cooked meats with thermometers and whisking leftovers into the refrigerator. But it's hard to keep food fresh and safe when you eat outdoors. On the second day of a camping trip last summer, for example, my daughter held up a bun and said "Mommy, why is my hot dog bun blue?" Horrified, I tossed the bun right away, along with a bag of its azure-tinged companions.

One in six Americans will get food poisoning this year, which causes about 3,000 deaths annually and, not surprisingly, spikes in the summer months. The CDC argues that forces such as the centralization of food production and increased consumption of food produced outside the United States make it increasingly difficult to prevent these outbreaks. Currently, Salmonella bacteria are infecting alfalfa and spicy sprouts in the northwestern U.S. and New Jersey, and a strain of E.coli bacteria in vegetables has killed almost 50 people in Germany and other parts of Europe.

It's scary stuff. But even without food contamination that originates in a farm or a factory, Americans do a pretty good job of giving themselves food poisoning on their own. To prevent food poisoning caused by lax food preparation habits at home, the USDA, FDA, CDC, and the Ad Council just launched a consumer ad campaign. Their clever, friendly campaign encourages everyone to keep food preparation areas clean, separate raw meat from other ingredients, cook food to the right temperature, and chill uneaten food adequately.

To remind us all to be careful with food this summer, here's a sample of the ads: